Wegovy Without Insurance

The headline number for Wegovy without insurance — roughly $1,349 per month at list price — is real, but it's not the number most cash-paying patients actually pay. Novo Nordisk has built out direct-to-consumer self-pay pricing that significantly reduces the out-of-pocket cost, and discount programs at retail pharmacies add another layer of variance.

This guide walks through what cash patients actually pay in 2026, the programs that lower the price, and the trade-offs to consider before committing. Pricing changes frequently — always verify the current number with the pharmacy or program before you commit to a refill schedule.

What it costs without help

Wegovy's list price (the wholesale acquisition cost manufacturers publish) is roughly $1,349 per package, which translates to a similar monthly figure for a standard one-month supply. Few patients pay that exact number at the counter — it's a reference point, not the typical retail price.

At chain and independent pharmacies, cash prices for Wegovy vary widely. Without a discount program, a single month's supply commonly lands in the $1,300 to $1,600 range. With a discount card like GoodRx, the price can drop several hundred dollars at participating pharmacies. The variability is wide enough that calling two or three pharmacies for a quote on the same dose is genuinely worth your time.

How to use savings programs

NovoCare Pharmacy's self-pay program is the most direct path for most cash patients. Your prescriber sends the prescription electronically to NovoCare, and the medication ships to your home. The program is restricted to patients without government-funded insurance (no Medicare, Medicaid, TRICARE, VA, or DOD) and requires a valid prescription.

Comparing the realistic paths

Once you know your options, the decision usually comes down to three real paths: retail pharmacy with or without a discount card, NovoCare Pharmacy self-pay, or the patient assistance program if you qualify. Retail pharmacy with a discount card is fastest but the highest cost. NovoCare Pharmacy self-pay is significantly cheaper for eligible patients but requires home delivery and may take longer for your first fill. Patient assistance is the lowest cost but has the narrowest eligibility.

If you're on a fixed budget, the difference between $349 per month at NovoCare and $1,300 to $1,600 at retail pharmacy is substantial enough that it's worth navigating the slightly more involved enrollment process. Build in a few days of buffer when starting or refilling — direct-to-consumer pharmacies generally ship rather than dispense in person.

Watch the dosing schedule

One overlooked cost factor: Wegovy's titration schedule starts you at 0.25 mg weekly and steps up roughly every four weeks to the maintenance dose of 2.4 mg (with a 7.2 mg high-dose option available beyond that for some patients). Each step uses a different pen strength, which means you'll move through several pen types in your first few months. Some self-pay programs price all doses equally; others vary by dose. Confirm what you'll pay at each step before you commit, especially if your budget is tight in the early titration months.

If your circumstances change

Two situations are worth flagging because they can substantially change your out-of-pocket cost.

First, employer open enrollment. If your employer offers a plan that covers anti-obesity medications, switching at open enrollment can change your monthly cost from several hundred dollars cash to a typical prescription copay. Check whether your employer offers multiple medical plans and whether any include weight-management drug coverage.

Second, Medicare eligibility. CMS's Medicare GLP-1 Bridge demonstration runs from July 1, 2026 through December 31, 2027 and covers Wegovy for eligible Part D beneficiaries at roughly $50 per month. Eligibility broadly requires BMI of 27 or higher with a qualifying condition such as cardiovascular disease or prediabetes, or BMI of 35 or higher. Program rules may change — confirm with your Part D plan and CMS before relying on this path.

Common questions

Keep exploring

Browse all GLP-1 guides.